Killing Cancer Cells by Activating the Cellular Intrinsic Nuclear Loss Program

Grant Project Details:

Awardee:
Wenqian Hu, PhD
Timeframe:
2019-2021
Location:
Mayo Clinic | Rochester, MN
Amount:
$250,000
Status:
In Process
Explore all RMM grants awarded since inception

Grant timeline: proposal, updates, reports

Grant Location

Mayo Clinic
200 First Street SW
Rochester, MN 55905

Grant Description

A major problem in leukemia treatment is the rise of drug-resistant mutations in the genome of cancer cells, which makes many well-designed cancer drugs ineffective over time. To solve this critical issue, here, we will develop a novel method of killing leukemia cells by inducing them to expel their nuclei.

Research Focus: Leukemias

 

Year 1 Progress Report: 

In the first year, this grant allowed us to recruited a talented Minnesotan student to my lab. We have made planned progress in constructing the CRISPR library for dissecting the genetic programs controlling the nuclear loss in mammalian cells. This information can be potentially used to kill leukemia cells.

Grant Awardee Biography

image of Wenqian Hu, PhD